Search

everythinglearnresearchcommunity

for

Search:↓

Losing eyelashes or eyebrows can be a sign of many different health problems and needs a careful approach to treat effectively.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

High doses of finasteride cause cell growth and tumors in mice.

Hairless mice lack fur due to a genetic mutation affecting skin response, not hormone issues.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Men with testicular cancer were less likely to experience baldness and severe acne.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Late pregnancy helps repair brain damage in rats due to the GABAergic system.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Exercise improves insulin sensitivity and hormone regulation in PCOS rats.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Thyroid hormone may speed up wound healing and hair growth, but more research is needed to understand its role in skin repair and use as a treatment.

Different types of dog hair loss are linked to problems starting the hair growth phase and early hair cycle ending.

The normal human prostate does not significantly affect blood DHT levels.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.